Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
DaVita Inc. DVA
$93.59
-$1.96 (-2.09%)
На 18:00, 12 мая 2023
+2.58%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
8677371781.00000000
-
week52high
103.63
-
week52low
65.28
-
Revenue
11609894000
-
P/E TTM
12
-
Beta
0.93252500
-
EPS
5.58000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 20:00
Описание компании
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| UBS | Buy | Neutral | 19 авг 2022 г. |
| Barclays | Equal-Weight | Equal-Weight | 04 авг 2022 г. |
| Deutsche Bank | Buy | Buy | 02 авг 2022 г. |
| Truist Securities | Hold | Hold | 22 июн 2022 г. |
| Truist Securities | Hold | Hold | 05 янв 2022 г. |
| UBS | Neutral | Buy | 31 окт 2022 г. |
| Truist Securities | Hold | Hold | 31 окт 2022 г. |
| Barclays | Equal-Weight | Equal-Weight | 31 окт 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Moore Gregory J. | A | 2202 | 677 | 15 ноя 2022 г. |
| NEHRA JOHN M | A | 677 | 677 | 15 ноя 2022 г. |
| Schechter Adam H | A | 81 | 81 | 15 ноя 2022 г. |
| YALE PHYLLIS R | A | 12452 | 677 | 15 ноя 2022 г. |
| Arway Pamela M | A | 21334 | 677 | 15 ноя 2022 г. |
| BERG CHARLES | A | 15733 | 677 | 15 ноя 2022 г. |
| DESOER BARBARA J | A | 677 | 677 | 15 ноя 2022 г. |
| DIAZ PAUL J | A | 14895 | 677 | 15 ноя 2022 г. |
| Hollar Jason M. | A | 994 | 677 | 15 ноя 2022 г. |
| NEHRA JOHN M | A | 15000 | 5000 | 01 ноя 2022 г. |
Новостная лента
2 Top-Rated Medical Stocks to Buy After Earnings
Zacks Investment Research
11 мая 2023 г. в 18:16
As we round out this week's earnings lineup, a few healthcare companies are standing out after topping their quarterly earnings expectations.
DVA vs. CHE: Which Stock Should Value Investors Buy Now?
Zacks Investment Research
10 мая 2023 г. в 12:55
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with DaVita HealthCare (DVA) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?
These 2 Stocks Are Popping -- and It Could Be Just the Beginning
The Motley Fool
09 мая 2023 г. в 14:04
Markets eased lower at midday on Tuesday. Palantir Technologies has seen strong demand for its AI-related software product.
DaVita (DVA) Tops Q1 Earnings Estimates, Ups FY23 EPS View
Zacks Investment Research
09 мая 2023 г. в 12:13
DaVita's (DVA) robust revenues in both segments drive its first-quarter performance.
DaVita Inc. (DVA) Q1 2023 Earnings Conference Call Transcript
Seeking Alpha
08 мая 2023 г. в 20:05
DaVita Inc. (NYSE:DVA ) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier J. Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Justin Lake - Wolfe Research Pito Chickering - Deutsche Bank Gary Taylor - Cowen Operator Good evening.